Lusutrombopag

Lusutrombopag

• CAS Number: 1110766-97-6
• UNSPSC Description: Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist, used for treatment of chronic liver disease.
• Target Antigen: Thrombopoietin Receptor
• Type: Reference compound
• Related Pathways: Immunology/Inflammation
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/Lusutrombopag.html
• Purity: 98.88
• Solubility: DMSO : 50 mg/mL (ultrasonic)
• Smiles: O=C(O)/C(C)=C/C1=C(Cl)C=C(C(NC2=NC(C3=CC=CC([C@@H](OCCCCCC)C)=C3OC)=CS2)=O)C=C1Cl
• Molecular Weight: 591.55
• References & Citations: [1]Kim ES, et al. Lusutrombopag: First Global Approval. Drugs. 2016 Jan;76(1):155-8.
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
• Clinical Information: Launched